skip navigation

Skip Nav

HIV/AIDS Clinical Trials

Clinical Trial Search Results

27 studies were found about tenofovir gel

Safety and Effectiveness Study of a Candidate Vaginal Microbicide for Prevention of HIV

Condition: HIV Infections

NCT ID: NCT00441298

Interventional Study of Mucosal and Antimicrobial Responses to Repeated Vaginal Applications of Tenofovir Gel in HIV Uninfected Women

Condition: HIV Infections

NCT ID: NCT00594373

Safety and Effectiveness of Tenofovir Gel in the Prevention of Human Immunodeficiency Virus (HIV-1) Infection in Women and the Effects of Tenofovir Gel on the Incidence of Herpes Simplex Virus (HSV-2) Infection

Condition: HIV Prevention

NCT ID: NCT01386294

Evaluating the Safety of Tenofovir Vaginal Gel in HIV-Uninfected Pregnant Women

Condition: HIV Infections

NCT ID: NCT01490671

Adherence and Acceptability to and Blood Levels of Tenofovir Gel and Tablets in HIV Uninfected Women

Condition: HIV Infections

NCT ID: NCT00592124

Pharmacokinetic Study of the Vaginal Microbicide Agent 1% Tenofovir Gel

Condition: HIV Infections

NCT ID: NCT00561496

Implementation Effectiveness and Safety of Tenofovir Gel Provision Through Family Planning Services

Condition: HIV

NCT ID: NCT01691768

Tenofovir Gel in Pregnancy and Lactation

Condition: HIV Infections

NCT ID: NCT01136759

Safety and Acceptability of a Vaginal Microbicide

Condition: HIV Infections; Hepatitis B, Chronic

NCT ID: NCT00111943

A Phase I Trial to Assess the Safety of Tenofovir Gel and Film Formulations: FAME 04

Condition: HIV

NCT ID: NCT01989663

Blood Levels of Tenofovir Gel in HIV Uninfected Pregnant Women Planning Cesarean Delivery

Condition: HIV Infections

NCT ID: NCT00540605

Rectal Microbicide Safety and Acceptability Trial of Topically Applied Tenofovir Compared With Oral Tablet

Condition: HIV Prevention; HIV Infections

NCT ID: NCT00984971

An Exploratory Rectal Safety Study of Three Tenofovir Gel Formulations

Condition: HIV Prevention

NCT ID: NCT01575418

Safety and Effectiveness of Tenofovir 1% Gel, Tenofovir Disproxil Fumarate, and Emtricitabine/Tenofovir Disoproxil Fumarate Tablets in Preventing HIV in Women

Condition: HIV Infections

NCT ID: NCT00705679

Safety and Acceptability Study of Oral Emtricitabine/Tenofovir Disoproxil Fumarate Tablet and Rectally-Applied Tenofovir Reduced-Glycerin 1% Gel

Condition: HIV

NCT ID: NCT01687218

Contraception and Menstrual Cycle Effect on Pharmacokinetics, Pharmacodynamics and Safety in Tenofovir Vaginal Gel Use

Condition: HIV Prevention

NCT ID: NCT01421368

In Vivo Drug Interaction Pharmacokinetic Study of Tenofovir 1% Gel and Three Commonly Used Vaginal Products

Condition: HIV Prevention

NCT ID: NCT01813162

Pharmacokinetic and Pharmacodynamic Study of Tenofovir 1% Gel

Condition: Prevention

NCT ID: NCT01369303

A Study to Compare Three Different Formulations of Tenofovir 1% Gel When Administered Rectally

Condition: HIV Prevention

NCT ID: NCT01575405

Influence of Reproductive Cycle and Menopause on HIV-1 Infection and TFV Gel Activity

Condition: HIV Prevention

NCT ID: NCT01810315

Microbicide Safety and Acceptability in Young Men

Condition: High Risk MSM; HIV Negative; 18-30 Years of Age

NCT ID: NCT01283360

Safety and Acceptability of the Anti-Microbe Vaginal Gel, PMPA Gel

Condition: HIV Infections

NCT ID: NCT00028132

Tenofovir Levels Following Local Application of Tenofovir Reduced-Glycerin 1% Gel

Condition: HIV Prevention

NCT ID: NCT01768962

Bone Mineral Density Substudy - An Ancillary Study to MTN-003

Condition: HIV Infections

NCT ID: NCT00729573

Effect of an Enfuvirtide-based Anti-HIV Drug Regimen on Latent HIV Reservoirs in Treatment Naive Adults

Condition: HIV Infections

NCT ID: NCT00051831

Safety and Effectiveness of Short-Term Anti-HIV Drug Therapy for Recent HIV-1 Infection

Condition: HIV Infections

NCT ID: NCT00414518

Study of Lopinavir/Ritonavir Tablets Versus Soft Gel Capsules and Once Daily Versus Twice Daily Administration, When Coadministered With Nucleoside Reverse Transcriptase Inhibitors in Antiretroviral Naive Human Immunodeficiency Virus Type 1 Infected Subjects

Condition: Human Immunodeficiency Virus Infections

NCT ID: NCT00262522